GPx4 inhibition leads to the imbalance of oxidative defenses and an increase in oxidative stress that consequently leads to ferroptosis; thus, inhibitors of GPx4 pathway can be exploited against highly aggressive forms of cancer such as glioblastoma, one of the most malignant brain tumors [164]. Here, GPX4 is linked to cancer.